Clinical Trial Update: Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and efficacy of abobotulinumtoxinA for treatment of glabellar lines has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Lines

Drugs mentioned

• AbobotulinumtoxinA (abobotulinumtoxinA)

Snippet

Sponsor: Galderma R&D | Conditions: Glabellar Frown Lines | Phase 2 | Status: COMPLETED | Results posted: 2021-02-11